Motivational smoking cessation counselling and community‐based follow‐up after hospitalisation for vascular disease: A randomised controlled trial
Addiction · 2026
DOI: 10.1111/add.70249 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Addiction, 2026. Verfasst von Karin Pleym und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Behavioural Sciences in Medicine, and the Faculty of Medicine, University of Oslo, Oslo, Norway. Hauptthemen laut MEDLINE: Smoking Cessation, Motivational Interviewing, Counseling, Vascular Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: DAM Foundation.
Abstract (Originalsprache)
Background and aims Evidence for motivational interviewing for smoking cessation is weak, with limited data on long‐term abstinence rates. This trial aimed to evaluate the effect of in‐hospital motivational interviewing‐based smoking cessation counselling combined with proactive referral to community‐based follow‐up on 6‐ and 12‐month continuous smoking abstinence in patients with atherosclerotic vascular disease.
Design
Multicentre, randomised, open‐label, blinded‐end‐point trial with 1:1 randomisation.
Setting
Three secondary care hospitals in Norway, with recruitment from November 2021 to October 2023.
Participants
Hospitalised patients with established atherosclerotic vascular disease who smoked ≥1 cigarette daily prior to unplanned or elective hospitalisation. A total of 221 were randomised (40% women, mean age 65.2 years), of whom 213 were included in the primary analysis due to 7 deaths and 1 withdrawal. Intervention and comparator In the intervention group ( n = 109), a trained nurse conducted a single 30‐minute motivational interviewing‐based counselling session, provided a leaflet explaining the local community‐based cessation programme, sent discharge information to the general practitioner and arranged for a personal telephone invitation from the centre staff to the follow‐up programme. In the control group ( n = 111), a physician gave brief cessation advice and the nurse provided a leaflet about the cessation programme and sent discharge information to the general practitioner.
Measurements
The primary outcome was self‐reported continuous smoking abstinence at 6 months. Secondary outcomes included biochemically validated abstinence (measurement of exhaled carbon monoxide) at 6 months and self‐reported abstinence at 12 months. Exploratory outcomes included recurrent vascular events over a median 18‐month follow‐up.
Findings
Smoking abstinence at 6 months was 49.5% (53/107) and 24.5% (26/106) in the intervention and control groups, respectively [odds ratio (OR) = 3.08, 95% confidence interval (CI) = 1.70–5.55, P < 0.001]. The number needed to treat to achieve one additional abstinence was 4 (95% CI = 3–9). Biochemically validated abstinence was 44.9% (48/107) and 20.8% (22/106) in the intervention and control groups, respectively (OR = 3.28, 95% CI = 1.76–6.12). At 12 months, smoking abstinence was 45.7% (48/105) and 27.5% (28/102) in the intervention and control groups, respectively (OR = 2.31, 95% CI = 1.27–4.20). After a median of 18‐month follow‐up, a prespecified vascular event occurred in 24.8% (27/109) and 34.2% (38/111) of intervention and control participants, respectively.
Conclusions
In‐hospital motivational counselling combined with proactive referral to follow‐up in a community‐based cessation programme approximately doubled long‐term smoking abstinence rates in patients with atherosclerotic vascular disease and reduced occurrence of a new vascular event.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Behavioural Sciences in Medicine, and the Faculty of Medicine, University of Oslo, Oslo, Norway.
- Department of Medicine, Drammen Hospital, Vestre Viken Trust, Drammen, Norway.
- Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway.
- Department of Medicine, Kongsberg Hospital, Vestre Viken Trust, Kongsberg, Norway.
- Department of Medicine, Ringerike Hospital, Vestre Viken Trust, Hønefoss, Norway.
- Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
ORCID-Profile: Karin Pleym
Förderung
- DAM Foundation
Zitieren
APA
Pleym, K., Sverre, E., Weedon-Fekjær, H., Kahlon, M. S., Stugaard, M., Husebye, E., Tonstad, S., Dammen, T., & Munkhaugen, J. (2026). Motivational smoking cessation counselling and community‐based follow‐up after hospitalisation for vascular disease: A randomised controlled trial. Addiction. https://doi.org/10.1111/add.70249
Vancouver
Pleym K, Sverre E, Weedon-Fekjær H, Kahlon MS, Stugaard M, Husebye E, et al. Motivational smoking cessation counselling and community‐based follow‐up after hospitalisation for vascular disease: A randomised controlled trial. Addiction. 2026. doi:10.1111/add.70249
BibTeX
@article{Pleym2026,
author = {Pleym, Karin and Sverre, Elise and Weedon-Fekjær, Harald and Kahlon, Mohpal Singh and Stugaard, Marie and Husebye, Einar and Tonstad, Serena and Dammen, Toril and Munkhaugen, John},
title = {Motivational smoking cessation counselling and community‐based follow‐up after hospitalisation for vascular disease: A randomised controlled trial},
journal = {Addiction},
year = {2026},
doi = {10.1111/add.70249}
}
EUVIMED